FDA Drugs recall ·
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose… recall
This is an FDA Class I recall — the most serious type.
- Recall number
- D-0787-2026
- Date
- (initiated July 24, 2026)
- Company / brand
- Baxter Healthcare Corporation
1 Baxter Pkwy, Deerfield, IL, United States - Category
- Drugs › Class I
- Classification
- Class I
- Status
- Ongoing
- Units affected
- 19,032 bags
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Why was it recalled?
Presence of Particulate Matter
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # LD175708, Exp Date: 14-Feb-2027.
Distribution
US Nationwide.
What does Class I mean?
Class I is the most serious FDA recall class: there is a reasonable probability that using or being exposed to the product will cause serious adverse health consequences or death.
Source: FDA (drugs), recall D-0787-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.